Biohaven Ltd. (BHVN)
10.78
-0.65
(-5.69%)
USD |
NYSE |
Oct 16, 16:00
10.79
+0.01
(+0.09%)
Pre-Market: 20:00
Biohaven Market Cap : 1.628B for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 1.628B |
| October 15, 2026 | 1.726B |
| October 14, 2026 | 1.651B |
| October 13, 2026 | 1.725B |
| October 12, 2026 | 1.784B |
| October 09, 2026 | 1.824B |
| October 08, 2026 | 1.802B |
| October 07, 2026 | 1.794B |
| October 06, 2026 | 1.824B |
| October 05, 2026 | 1.959B |
| October 02, 2026 | 1.944B |
| October 01, 2026 | 1.984B |
| September 30, 2026 | 2.016B |
| September 29, 2026 | 2.007B |
| September 28, 2026 | 2.004B |
| September 25, 2026 | 1.962B |
| September 24, 2026 | 1.992B |
| September 23, 2026 | 2.064B |
| September 22, 2026 | 2.243B |
| September 21, 2026 | 2.147B |
| September 18, 2026 | 2.057B |
| September 17, 2026 | 2.098B |
| September 16, 2026 | 1.815B |
| September 15, 2026 | 1.864B |
| September 14, 2026 | 1.909B |
| Date | Value |
|---|---|
| September 11, 2026 | 1.919B |
| September 10, 2026 | 1.932B |
| September 09, 2026 | 2.265B |
| September 08, 2026 | 2.223B |
| September 04, 2026 | 2.369B |
| September 03, 2026 | 2.395B |
| September 02, 2026 | 2.369B |
| September 01, 2026 | 2.377B |
| August 31, 2026 | 2.306B |
| August 28, 2026 | 2.327B |
| August 27, 2026 | 2.434B |
| August 26, 2026 | 2.560B |
| August 25, 2026 | 2.172B |
| August 24, 2026 | 2.066B |
| August 21, 2026 | 2.092B |
| August 20, 2026 | 2.039B |
| August 19, 2026 | 2.135B |
| August 18, 2026 | 2.049B |
| August 17, 2026 | 2.184B |
| August 14, 2026 | 2.211B |
| August 13, 2026 | 2.243B |
| August 12, 2026 | 2.173B |
| August 11, 2026 | 2.188B |
| August 10, 2026 | 2.196B |
| August 07, 2026 | 2.214B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovelStem International Corp. | 0.4687M |
| Brainstorm Cell Therapeutics, Inc. | 8.597M |
| Summit Therapeutics, Inc. | 11.60B |
| Kezar Life Sciences, Inc. | 53.76M |
| Protara Therapeutics, Inc. | 137.07M |
Market Cap Related Metrics
| Price to Book Value | 133.20 |
| Price | 10.78 |
| Earnings Yield | -43.10% |